Global Health Limited Stock

Equities

MEDANTA

INE474Q01031

Healthcare Facilities & Services

End-of-day quote NSE India S.E. 06:00:00 2024-05-17 pm EDT 5-day change 1st Jan Change
1,404 INR -1.20% Intraday chart for Global Health Limited -0.56% +46.39%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 32.75B 393M Sales 2025 * 39.15B 470M Capitalization 377B 4.53B
Net income 2024 4.78B 57.44M Net income 2025 * 6.19B 74.4M EV / Sales 2024 10.8 x
Net cash position 2024 * 7.08B 85.03M Net cash position 2025 * 8.59B 103M EV / Sales 2025 * 9.41 x
P/E ratio 2024
74.2 x
P/E ratio 2025 *
60.2 x
Employees 7,829
Yield 2024 *
0.2%
Yield 2025 *
0.26%
Free-Float 31.93%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.20%
1 week-0.56%
Current month-2.84%
1 month+0.03%
3 months+0.62%
6 months+55.58%
Current year+46.39%
More quotes
1 week
1 380.00
Extreme 1380
1 430.00
1 month
1 353.50
Extreme 1353.5
1 511.00
Current year
938.45
Extreme 938.45
1 513.90
1 year
557.65
Extreme 557.65
1 513.90
3 years
390.55
Extreme 390.55
1 513.90
5 years
390.55
Extreme 390.55
1 513.90
10 years
390.55
Extreme 390.55
1 513.90
More quotes
Managers TitleAgeSince
Chief Executive Officer - 10-11-30
78 -
Chief Tech/Sci/R&D Officer - 14-11-05
Members of the board TitleAgeSince
Director/Board Member 64 21-07-07
Director/Board Member 67 21-03-22
Chairman 78 -
More insiders
Date Price Change Volume
24-05-18 1,404 -1.20% 28,829
24-05-17 1,421 +1.88% 173,858
24-05-16 1,395 -0.43% 118,401
24-05-15 1,401 -0.84% 72,531
24-05-14 1,413 +1.73% 121,246

End-of-day quote NSE India S.E., May 17, 2024

More quotes
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare, and telemedicine services. It provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1,404 INR
Average target price
1,353 INR
Spread / Average Target
-3.66%
Consensus
  1. Stock Market
  2. Equities
  3. MEDANTA Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW